General Information of This Drug (ID: DMM7TBO)

Drug Name
MORAb-022   DMM7TBO
Synonyms Antibody (inflammation/autoimmune disease), Morphotek
Drug Type
Antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Autoimmune diabetes DISW6UF1 5A10 Phase 1 [1]
Rheumatoid arthritis DISTSB4J FA20 Phase 1 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT01357759) Safety and Tolerability of MORAb-022 in Healthy and Rheumatoid Arthritis Subjects. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)